Valion Bio, Inc. Cash Provided by (Used in) Operating Activities, Discontinued Operations
Valion Bio, Inc. (VBIO) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of $29.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2026-08-14
- Valion Bio, Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2026-06-30 was -$7.00K.
- Valion Bio, Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2026-03-31 was $36.00K.
- Valion Bio, Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2025-06-30 was -$233.00K.
- Valion Bio, Inc. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2025-03-31 was -$60.00K.
- Valion Bio, Inc. cash provided by (used in) operating activities, discontinued operations for fiscal 2025 was -$380.00K.
- Valion Bio, Inc. cash provided by (used in) operating activities, discontinued operations for fiscal 2024 was -$643.00K.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month |
|---|---|---|---|
| 2026-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $29.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $36.00K 10-Q · filed 2026-05-14 | ||
| 2025-12-31 | -$380.00K 10-K · filed 2026-03-30 | ||
| 2025-06-30 | -$233.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$293.00K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | -$60.00K 10-Q · filed 2026-05-14 | ||
| 2024-12-31 | -$643.00K 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |